Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
Cybin Inc. (HELP)
Company Research
Source: GlobeNewswire
Proven human resources and organizational strategist brings more than two decades of leadership across the pharmaceutical industryAppointment supports Helus Pharma’s continued maturation as the company advances its novel clinical pipeline NEW YORK and TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Helus PharmaTM (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced the appointment of Jill Conwell as Chief People Officer, effective immediately. Conwell brings more than two decades of leadership experience in the life sciences industry, with expertise spanning organizational strategy, talent development, corporate communications, investor relations, and building commercial teams. Throughout her career, she has helped biotechnology and pharmaceutical companies design and scale organizations to support evolving business strategies, including periods of rapid growth, pipel
Show less
Read more
Impact Snapshot
Event Time:
HELP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HELP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HELP alerts
High impacting Cybin Inc. news events
Weekly update
A roundup of the hottest topics
HELP
News
- Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer [Yahoo! Finance]Yahoo! Finance
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- A Look At Cybin (HELP) Valuation After Positive Phase 2 HLP004 Anxiety Data [Yahoo! Finance]Yahoo! Finance
- Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder [Yahoo! Finance]Yahoo! Finance
- Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety DisorderGlobeNewswire
HELP
Earnings
- 2/13/26 - Miss
HELP
Sec Filings
- 3/23/26 - Form D
- 3/12/26 - Form 6-K
- 3/5/26 - Form 6-K
- HELP's page on the SEC website